Also mentions Nasdaq:
NASDAQ OMX Reports Record Fourth Quarter 2013 Results
x hide permanently

Menlo Therapeutics Announces New Board Member Elisabeth Sandoval

REDWOOD CITY, Calif., March 20, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), today announced that Elisabeth Sandoval has been appointed as a member of Menlo’s Board of Directors, effective immediately...

Mentions: Nasdaq Elisabeth Sandoval Menlo Therapeutics